首页> 美国卫生研究院文献>Immunology >Inactivation of C-1 inhibitor by proteases: demonstration by a monoclonal antibody of a neodeterminant on inactivated non-complexed C-1 inhibitor.
【2h】

Inactivation of C-1 inhibitor by proteases: demonstration by a monoclonal antibody of a neodeterminant on inactivated non-complexed C-1 inhibitor.

机译:蛋白酶灭活C-1抑制剂:通过灭活的非复杂的C-1抑制剂的新决定簇的单克隆抗体证明。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Monoclonal antibodies were raised against kallikrein-C-1 inhibitor and factor XIIa-C-1 inhibitor complexes. One of the monoclonal antibodies (KII) appeared to react predominantly with C-1 inhibitor complexes in an ELISA. However, the apparent binding of KII to C-1 inhibitor complexes was probably due to the presence of proteolytically inactivated C-1 inhibitor in the complex mixture used for the coating:KII did not bind either kallikrein-C-1 inhibitor or factor XIIa-C-1 inhibitor complexes generated in plasma by dextran sulphate. SDS-PAGE analysis of C-1 inhibitor incubated with proteases revealed that KII-reactive C-1 inhibitor has a lower molecular weight than native C-1 inhibitor. We propose that the determinant that reacts with KII is exposed after cleavage of C-1 inhibitor in its reactive site. The monoclonal antibody KII will enable us to study the inactivation of C-1 inhibitor in human inflammatory disease.
机译:产生针对激肽释放酶-C-1抑制剂和因子XIIa-C-1抑制剂复合物的单克隆抗体。一种单克隆抗体(KII)在ELISA中似乎主要与C-1抑制剂复合物反应。但是,KII与C-1抑制剂复合物的表观结合可能是由于在用于涂层的复合物混合物中存在蛋白水解失活的C-1抑制剂:KII既不结合激肽释放酶-C-1抑制剂也不结合因子XIIa-硫酸葡聚糖在血浆中生成的C-1抑制剂复合物。对与蛋白酶一起孵育的C-1抑制剂的SDS-PAGE分析表明,与KII反应的C-1抑制剂的分子量低于天然C-1抑制剂。我们建议与CII反应的行列式在其反应位点裂解C-1抑制剂后暴露出来。单克隆抗体KII将使我们能够研究人类炎性疾病中C-1抑制剂的失活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号